Dr. Reddy's Tries To Nip New Nexium Spat In The Bud

Law360, New York (June 6, 2008, 12:00 AM EDT) -- Hoping to nip another Nexium spat in the bud, Dr Reddy's Laboratories Ltd. has asked a district court to issue a declaratory judgment of noninfringement, as the battle over the Indian generics maker's bid to market a knockoff version of AstraZeneca AB's best-selling heartburn treatment continues to unfold.

On Friday, Dr Reddy's revealed that it is seeking a declaratory ruling from the U.S. District Court for the District of New Jersey on six Nexium patents, pointing out that the company faces “uncertainty and great potential risk”...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.